{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:04:18Z","timestamp":1740107058518,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304348\/2019-8"],"award-info":[{"award-number":["304348\/2019-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00432-020-03208-8","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T08:02:26Z","timestamp":1586764946000},"page":"1523-1532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort"],"prefix":"10.1007","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-8047","authenticated-orcid":false,"given":"Glauco Akelinghton Freire","family":"Vitiello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7292-9861","authenticated-orcid":false,"given":"Nathalia","family":"de Sousa Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8218-8518","authenticated-orcid":false,"given":"Marla Karine","family":"Amarante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6280-0140","authenticated-orcid":false,"given":"Bruna Karina","family":"Banin-Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clodoaldo Zago","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9666-6963","authenticated-orcid":false,"given":"Karen Braj\u00e3o","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-8621","authenticated-orcid":false,"given":"Roberta","family":"Losi-Guembarovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-8200","authenticated-orcid":false,"given":"Maria Angelica Ehara","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"3208_CR1","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature11881","volume":"494","author":"MB Burns","year":"2013","unstructured":"Burns MB et al (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494:366\u2013370. https:\/\/doi.org\/10.1038\/nature11881","journal-title":"Nature"},{"key":"3208_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/ng.2701","volume":"45","author":"MB Burns","year":"2013","unstructured":"Burns MB, Temiz NA, Harris RS (2013) Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 45:977\u2013983. https:\/\/doi.org\/10.1038\/ng.2701","journal-title":"Nat Genet"},{"key":"3208_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/2319-4170.148904","volume":"38","author":"MB Burns","year":"2015","unstructured":"Burns MB, Leonard B, Harris RS (2015) APOBEC3B: pathological consequences of an innate immune DNA mutator. Biomed J 38:102\u2013110. https:\/\/doi.org\/10.4103\/2319-4170.148904","journal-title":"Biomed J"},{"key":"3208_CR4","doi-asserted-by":"publisher","first-page":"261b","DOI":"10.1126\/science.296.5566.261b","volume":"296","author":"HM Cann","year":"2002","unstructured":"Cann HM (2002) A Human Genome Diversity Cell Line Panel. Science 296:261b\u2013262. https:\/\/doi.org\/10.1126\/science.296.5566.261b","journal-title":"Science"},{"key":"3208_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6129","author":"V Caval","year":"2014","unstructured":"Caval V, Susp\u00e8ne R, Shapira M, Vartanian J-P, Wain-Hobson S (2014) A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3\u2032UTR enhances chromosomal DNA damage. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms6129","journal-title":"Nat Commun"},{"key":"3208_CR6","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1073\/pnas.1424869112","volume":"112","author":"DW Cescon","year":"2015","unstructured":"Cescon DW, Haibe-Kains B, Mak TW (2015) APOBEC3Bexpression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation. Proc Natl Acad Sci 112:2841\u20132846. https:\/\/doi.org\/10.1073\/pnas.1424869112","journal-title":"Proc Natl Acad Sci"},{"key":"3208_CR7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/ng.3378","volume":"47","author":"K Chan","year":"2015","unstructured":"Chan K et al (2015) An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat Genet 47:1067\u20131072. https:\/\/doi.org\/10.1038\/ng.3378","journal-title":"Nat Genet"},{"key":"3208_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12920-019-0579-3","volume":"12","author":"Z Chen","year":"2019","unstructured":"Chen Z et al (2019) Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types. BMC Med Genomics 12:131. https:\/\/doi.org\/10.1186\/s12920-019-0579-3","journal-title":"BMC Med Genomics"},{"key":"3208_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14568-7","author":"CB Driscoll","year":"2020","unstructured":"Driscoll CB et al (2020) APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-14568-7","journal-title":"Nat Commun"},{"key":"3208_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/carcin\/bgx131","volume":"39","author":"LB Gansmo","year":"2018","unstructured":"Gansmo LB, Romundstad P, Hveem K, Vatten L, Nik-Zainal S, L\u00f8nning PE, Knappskog S (2018) APOBEC3A\/B deletion polymorphism and cancer risk. Carcinogenesis 39:118\u2013124. https:\/\/doi.org\/10.1093\/carcin\/bgx131","journal-title":"Carcinogenesis"},{"key":"3208_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00432-015-2038-7","volume":"142","author":"S G\u00f6hler","year":"2015","unstructured":"G\u00f6hler S et al (2015) Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population. J Cancer Res Clin Oncol 142:273\u2013276. https:\/\/doi.org\/10.1007\/s00432-015-2038-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"3208_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13107","author":"M Hashemi","year":"2019","unstructured":"Hashemi M, Moazeni-Roodi A, Taheri M (2019) Association of APOBEC3 deletion with cancer risk: a meta-analysis of 26225 cases and 37 201 controls Asia-Pacific. J Clin Oncol. https:\/\/doi.org\/10.1111\/ajco.13107","journal-title":"J Clin Oncol"},{"key":"3208_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.molmed.2015.02.007","volume":"21","author":"S Henderson","year":"2015","unstructured":"Henderson S, Fenton T (2015) APOBEC3 genes: retroviral restriction factors to cancer drivers. Trends Mol Med 21:274\u2013284. https:\/\/doi.org\/10.1016\/j.molmed.2015.02.007","journal-title":"Trends Mol Med"},{"key":"3208_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1042-9","author":"N Kanu","year":"2016","unstructured":"Kanu N et al (2016) DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer. Genome Biol. https:\/\/doi.org\/10.1186\/s13059-016-1042-9","journal-title":"Genome Biol"},{"key":"3208_CR15","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1073\/pnas.1504447112","volume":"112","author":"FS Kehdy","year":"2015","unstructured":"Kehdy FS et al (2015) Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations. Proc Natl Acad Sci USA 112:8696\u20138701. https:\/\/doi.org\/10.1073\/pnas.1504447112","journal-title":"Proc Natl Acad Sci USA"},{"key":"3208_CR16","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1371\/journal.pgen.0030063","volume":"3","author":"JM Kidd","year":"2007","unstructured":"Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE (2007) Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 3:e63. https:\/\/doi.org\/10.1371\/journal.pgen.0030063","journal-title":"PLoS Genet"},{"key":"3208_CR17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19400","author":"K Klonowska","year":"2017","unstructured":"Klonowska K et al (2017) The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.19400","journal-title":"Oncotarget"},{"key":"3208_CR18","doi-asserted-by":"publisher","first-page":"e1601737","DOI":"10.1126\/sciadv.1601737","volume":"2","author":"EK Law","year":"2016","unstructured":"Law EK et al (2016) The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. Sci Adv 2:e1601737. https:\/\/doi.org\/10.1126\/sciadv.1601737","journal-title":"Sci Adv"},{"key":"3208_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ajhb.20976","author":"TC Lins","year":"2009","unstructured":"Lins TC, Vieira RG, Abreu BS, Grattapaglia D, Pereira RW (2009) Genetic composition of Brazilian population samples based on a set of twenty-eight ancestry informative SNPs. Am J Hum Biol. https:\/\/doi.org\/10.1002\/ajhb.20976","journal-title":"Am J Hum Biol"},{"key":"3208_CR20","doi-asserted-by":"publisher","first-page":"e0161731","DOI":"10.1371\/journal.pone.0161731","volume":"11","author":"J Liu","year":"2016","unstructured":"Liu J et al (2016) The 29.5 kb APOBEC3B deletion polymorphism is not associated with clinical outcome of breast cancer. PLoS ONE 11:e0161731. https:\/\/doi.org\/10.1371\/journal.pone.0161731","journal-title":"PLoS ONE"},{"key":"3208_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jnci\/djt018","volume":"105","author":"J Long","year":"2013","unstructured":"Long J et al (2013) A common deletion in the APOBEC3 genes and breast cancer risk. J Natl Cancer Inst 105:573\u2013579. https:\/\/doi.org\/10.1093\/jnci\/djt018","journal-title":"J Natl Cancer Inst"},{"key":"3208_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2210-8","author":"C Marouf","year":"2016","unstructured":"Marouf C, G\u00f6hler S, Filho MIDS, Hajji O, Hemminki K, Nadifi S, F\u00f6rsti A (2016) Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-016-2210-8","journal-title":"BMC Cancer"},{"key":"3208_CR23","doi-asserted-by":"publisher","first-page":"12099","DOI":"10.1074\/jbc.RA119.008443","volume":"294","author":"JL McCann","year":"2019","unstructured":"McCann JL, Klein MM, Leland EM, Law EK, Brown WL, Salamango DJ, Harris RS (2019) The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1. J Biol Chem 294:12099\u201312111. https:\/\/doi.org\/10.1074\/jbc.RA119.008443","journal-title":"J Biol Chem"},{"key":"3208_CR24","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/humu.23220","volume":"38","author":"MS Naslavsky","year":"2017","unstructured":"Naslavsky MS et al (2017) Exomic variants of an elderly cohort of Brazilians in the ABraOM database. Hum Mutat 38:751\u2013763. https:\/\/doi.org\/10.1002\/humu.23220","journal-title":"Hum Mutat"},{"key":"3208_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal S et al (2012) Mutational processes molding the genomes of 21 breast cancers. Cell 149:979\u2013993. https:\/\/doi.org\/10.1016\/j.cell.2012.04.024","journal-title":"Cell"},{"key":"3208_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ng.2955","volume":"46","author":"S Nik-Zainal","year":"2014","unstructured":"Nik-Zainal S et al (2014) Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nat Genet 46:487\u2013491. https:\/\/doi.org\/10.1038\/ng.2955","journal-title":"Nat Genet"},{"key":"3208_CR27","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1084\/jem.20030275","volume":"197","author":"IM Okazaki","year":"2003","unstructured":"Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, Honjo T (2003) Constitutive expression of AID leads to tumorigenesis. J Exp Med 197:1173\u20131181. https:\/\/doi.org\/10.1084\/jem.20030275","journal-title":"J Exp Med"},{"key":"3208_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1073\/pnas.0126614100","volume":"100","author":"FC Parra","year":"2003","unstructured":"Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD (2003) Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 100:177\u2013182. https:\/\/doi.org\/10.1073\/pnas.0126614100","journal-title":"Proc Natl Acad Sci USA"},{"key":"3208_CR29","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1590\/S0100-879X2009005000026","volume":"42","author":"SD Pena","year":"2009","unstructured":"Pena SD, Bastos-Rodrigues L, Pimenta JR, Bydlowski SP (2009) DNA tests probe the genomic ancestry of Brazilians. Braz J Med Biol 42:870\u2013876","journal-title":"Braz J Med Biol"},{"key":"3208_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.celrep.2015.08.066","volume":"13","author":"M Periyasamy","year":"2015","unstructured":"Periyasamy M et al (2015) APOBEC3B-mediated cytidine deamination is required for estrogen receptor action in breast cancer. Cell Rep 13:108\u2013121. https:\/\/doi.org\/10.1016\/j.celrep.2015.08.066","journal-title":"Cell Rep"},{"key":"3208_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000096872","volume":"62","author":"JR Pimenta","year":"2006","unstructured":"Pimenta JR et al (2006) Color and genomic ancestry in Brazilians: a study with forensic microsatellites. Hum Hered 62:190\u2013195. https:\/\/doi.org\/10.1159\/000096872","journal-title":"Hum Hered"},{"issue":"Suppl 2","key":"3208_CR32","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","volume":"24","author":"A Prat","year":"2015","unstructured":"Prat A et al (2015) Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast 24(Suppl 2):S26\u201335. https:\/\/doi.org\/10.1016\/j.breast.2015.07.008","journal-title":"Breast"},{"key":"3208_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cell.2004.08.006","volume":"118","author":"AR Ramiro","year":"2004","unstructured":"Ramiro AR et al (2004) AID is required for c-myc\/IgH chromosome translocations in vivo. Cell 118:431\u2013438. https:\/\/doi.org\/10.1016\/j.cell.2004.08.006","journal-title":"Cell"},{"key":"3208_CR34","doi-asserted-by":"publisher","first-page":"11983","DOI":"10.1007\/s13277-016-5064-4","volume":"37","author":"S Revathidevi","year":"2016","unstructured":"Revathidevi S et al (2016) Analysis of APOBEC3A\/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation. Tumor Biol 37:11983\u201311990. https:\/\/doi.org\/10.1007\/s13277-016-5064-4","journal-title":"Tumor Biol"},{"key":"3208_CR35","first-page":"103","volume":"4","author":"M Rezaei","year":"2015","unstructured":"Rezaei M, Hashemi M, Hashemi SM, Mashhadi MA, Taheri M (2015) APOBEC3 deletion is associated with breast cancer risk in a sample of Southeast Iranian population. Int J Mol Cell Med 4:103\u2013108","journal-title":"Int J Mol Cell Med"},{"key":"3208_CR36","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts SA et al (2013) APOBEC3 deletion is associated with breast cancer risk in a sample of Southeast Iranian population. Nat Genet 45:970\u2013976. https:\/\/doi.org\/10.1038\/ng.2702","journal-title":"Nat Genet"},{"key":"3208_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12672-014-0196-8","volume":"5","author":"AM Sieuwerts","year":"2014","unstructured":"Sieuwerts AM et al (2014) Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers. Hormones Cancer 5:405\u2013413. https:\/\/doi.org\/10.1007\/s12672-014-0196-8","journal-title":"Hormones Cancer"},{"key":"3208_CR38","doi-asserted-by":"publisher","first-page":"12910","DOI":"10.1038\/ncomms12910","volume":"7","author":"M Smid","year":"2016","unstructured":"Smid M et al (2016) Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration. Nat Commun 7:12910. https:\/\/doi.org\/10.1038\/ncomms12910","journal-title":"Nat Commun"},{"key":"3208_CR39","doi-asserted-by":"publisher","first-page":"e73641","DOI":"10.1371\/journal.pone.0073641","volume":"8","author":"P Sommer","year":"2013","unstructured":"Sommer P, Mussil B, Susp\u00e8ne R, Aynaud M-M, Gauvrit A, Vartanian J-P, Wain-Hobson S (2013) Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death. PLoS ONE 8:e73641. https:\/\/doi.org\/10.1371\/journal.pone.0073641","journal-title":"PLoS ONE"},{"key":"3208_CR40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/ng1571","volume":"37","author":"P Stephens","year":"2005","unstructured":"Stephens P et al (2005) A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet 37:590\u2013592. https:\/\/doi.org\/10.1038\/ng1571","journal-title":"Nat Genet"},{"key":"3208_CR41","doi-asserted-by":"publisher","first-page":"e0168090","DOI":"10.1371\/journal.pone.0168090","volume":"11","author":"E Tokunaga","year":"2016","unstructured":"Tokunaga E et al (2016) Expression of APOBEC3B mRNA in primary breast cancer of Japanese women. PLoS ONE 11:e0168090. https:\/\/doi.org\/10.1371\/journal.pone.0168090","journal-title":"PLoS ONE"},{"key":"3208_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-019-05370-1","author":"GAF Vitiello","year":"2019","unstructured":"Vitiello GAF, Amarante MK, Banin-Hirata BK, Campos CZ, de Oliveira KB, Losi-Guembarovski R, Watanabe MAE (2019) Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-019-05370-1","journal-title":"Breast Cancer Res Treat"},{"key":"3208_CR43","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00432-018-2585-9","volume":"144","author":"GAF Vitiello","year":"2018","unstructured":"Vitiello GAF et al (2018) Transforming growth factor beta 1 (TGFbeta1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis. J Cancer Res Clin Oncol 144:645\u2013655. https:\/\/doi.org\/10.1007\/s00432-018-2585-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"3208_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cyto.2017.09.019","volume":"103","author":"GAF Vitiello","year":"2018","unstructured":"Vitiello GAF, Losi Guembarovski R, Amarante MK, Ceribelli JR, Carmelo ECB, Watanabe MAE (2018) Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups. Cytokine 103:121\u2013126. https:\/\/doi.org\/10.1016\/j.cyto.2017.09.019","journal-title":"Cytokine"},{"key":"3208_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13058-016-0717-1","volume":"18","author":"WX Wen","year":"2016","unstructured":"Wen WX et al (2016) Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation. Breast Cancer Res 18:56. https:\/\/doi.org\/10.1186\/s13058-016-0717-1","journal-title":"Breast Cancer Res"},{"key":"3208_CR46","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/carcin\/bgt185","volume":"34","author":"D Xuan","year":"2013","unstructured":"Xuan D et al (2013) APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis 34:2240\u20132243. https:\/\/doi.org\/10.1093\/carcin\/bgt185","journal-title":"Carcinogenesis"},{"key":"3208_CR47","doi-asserted-by":"publisher","first-page":"8483","DOI":"10.1073\/pnas.92.18.8483","volume":"92","author":"S Yamanaka","year":"1995","unstructured":"Yamanaka S et al (1995) Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci USA 92:8483\u20138487. https:\/\/doi.org\/10.1073\/pnas.92.18.8483","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03208-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T23:51:05Z","timestamp":1618271465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03208-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["3208"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03208-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2020,4,13]]},"assertion":[{"value":"19 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee for Research Involving Human Subjects from Londrina State University (CEP\/UEL 189\/2013 \u2013 CAAE 17123113400005231).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}